RS60667B1 - Derivati di(fenilpropanoid)glicerola za lečenje kancera - Google Patents

Derivati di(fenilpropanoid)glicerola za lečenje kancera

Info

Publication number
RS60667B1
RS60667B1 RS20200931A RSP20200931A RS60667B1 RS 60667 B1 RS60667 B1 RS 60667B1 RS 20200931 A RS20200931 A RS 20200931A RS P20200931 A RSP20200931 A RS P20200931A RS 60667 B1 RS60667 B1 RS 60667B1
Authority
RS
Serbia
Prior art keywords
phenylpropanoid
glycerol
cancer
derivatives
treatment
Prior art date
Application number
RS20200931A
Other languages
English (en)
Inventor
Alexander Macgregor
Original Assignee
Alexander Macgregor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexander Macgregor filed Critical Alexander Macgregor
Publication of RS60667B1 publication Critical patent/RS60667B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
RS20200931A 2009-10-09 2010-10-08 Derivati di(fenilpropanoid)glicerola za lečenje kancera RS60667B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25028709P 2009-10-09 2009-10-09
PCT/CA2010/001613 WO2011041907A1 (en) 2009-10-09 2010-10-08 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer
EP10821532.8A EP2486026B1 (en) 2009-10-09 2010-10-08 Derivatives of di(phenylpropanoid) glycerol for the treatment of cancer

Publications (1)

Publication Number Publication Date
RS60667B1 true RS60667B1 (sr) 2020-09-30

Family

ID=43352967

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20200931A RS60667B1 (sr) 2009-10-09 2010-10-08 Derivati di(fenilpropanoid)glicerola za lečenje kancera

Country Status (19)

Country Link
US (2) US9061993B2 (sr)
EP (1) EP2486026B1 (sr)
JP (1) JP5529280B2 (sr)
CN (1) CN102264713A (sr)
BR (1) BR112012008204A2 (sr)
CA (1) CA2715662C (sr)
CY (1) CY1123161T1 (sr)
DK (1) DK2486026T3 (sr)
ES (1) ES2810906T3 (sr)
HR (1) HRP20201217T1 (sr)
HU (1) HUE051549T2 (sr)
LT (1) LT2486026T (sr)
MX (1) MX360417B (sr)
MY (2) MY160378A (sr)
PL (1) PL2486026T3 (sr)
PT (1) PT2486026T (sr)
RS (1) RS60667B1 (sr)
SI (1) SI2486026T1 (sr)
WO (1) WO2011041907A1 (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues
US9402834B2 (en) 2014-10-21 2016-08-02 Ions Pharmaceutical S.À R.L. Human therapeutic agents
US9907786B2 (en) 2014-10-21 2018-03-06 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof
US10092550B2 (en) 2014-10-21 2018-10-09 Ions Pharmaceutical S.À R.L. Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857873A (en) 1974-02-11 1974-12-31 Warner Lambert Co 3-hydroxy-5-(3-(substituted-amino)-2-hydroxypropoxy)-benzyl alcohols
CH648753A5 (de) * 1981-07-22 1985-04-15 Givaudan & Cie Sa Lichtschutzmittel.
CN1238333C (zh) * 2003-06-18 2006-01-25 清华大学 药物化合物菠萝酰酯及其制备方法和用途
US7713556B2 (en) 2006-12-08 2010-05-11 Henry Lowe Anti-tumor and anti-inflammatory extracts of plant biomass and their uses
EP2104659B1 (en) * 2007-01-08 2015-07-29 AndroScience Corporation Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and uses thereof
TWI383251B (zh) * 2008-01-16 2013-01-21 Eternal Chemical Co Ltd 感光型聚醯亞胺
KR101074149B1 (ko) * 2009-04-15 2011-10-17 한밭대학교 산학협력단 신규 폴리페놀/폴리페놀 컨쥬게이트 화합물 및 그의 용도
US8907117B2 (en) * 2011-09-08 2014-12-09 Henry Lowe Anti-tumor and anti-inflammatory dicinnamoyl-glycerol esters and their analogues

Also Published As

Publication number Publication date
PT2486026T (pt) 2020-08-21
JP2013507327A (ja) 2013-03-04
US20110086912A1 (en) 2011-04-14
US20150246014A1 (en) 2015-09-03
CY1123161T1 (el) 2021-10-29
WO2011041907A1 (en) 2011-04-14
MX2012004160A (es) 2012-09-07
MY160378A (en) 2017-03-15
US10052301B2 (en) 2018-08-21
ES2810906T3 (es) 2021-03-09
PL2486026T3 (pl) 2020-11-02
HRP20201217T1 (hr) 2020-12-11
CN102264713A (zh) 2011-11-30
US9061993B2 (en) 2015-06-23
SI2486026T1 (sl) 2020-10-30
MX360417B (es) 2018-10-25
LT2486026T (lt) 2020-09-10
EP2486026A4 (en) 2015-07-01
DK2486026T3 (da) 2020-08-17
EP2486026A1 (en) 2012-08-15
CA2715662C (en) 2013-05-07
BR112012008204A2 (pt) 2017-07-18
EP2486026B1 (en) 2020-06-24
MY187188A (en) 2021-09-09
JP5529280B2 (ja) 2014-06-25
HUE051549T2 (hu) 2021-10-28
CA2715662A1 (en) 2010-12-14

Similar Documents

Publication Publication Date Title
LT2959900T (lt) Junginys, skirtas vėžio gydymui
PL2482849T3 (pl) Skojarzona immunoterapia w leczeniu nowotworu
ZA201107879B (en) Composition for the treatment of prostate cancer
IL218971A0 (en) Sulfoxide derivatives for the treatment of tumours
IL213761A0 (en) Novel ortho-aminoamides for the treatment of cancer
SI2605764T1 (sl) Sestavki za zdravljenje raka
IL214349A0 (en) Compositions and methods for the treatment of cancer
EP2355843B8 (en) Vaccine for the prevention of breast cancer recurrence
EP2437738A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
IL210066A0 (en) Novel ortho-aminoanilides for the treatment of cancer
EP2486026A4 (en) DERIVATIVES OF DI (PHENYLPROPANOID-) GLYCEROL FOR CANCER TREATMENT
EP2411031A4 (en) Methods and compositions for the treatment of cancer
IL220134A0 (en) Thiazole derivatives for the treatment of diseases such as cancer
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.
AU2009900764A0 (en) Treatment of cancer
GB0907571D0 (en) The reason of all cancer types